Materialise NV ADR
Materialise NV ADR is a Belgium-based technology company focused on additive manufacturing, also known as 3D printing, and medical software solutions. Materialise develops proprietary software that helps industrial users design, prepare, and manage reliable 3D printing production, while also offering medical software, devices, and related services for healthcare applications. Its operations are organized across three core segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The company also provides 3D printing and production services to industrial and commercial customers across sectors such as healthcare, automotive, aerospace, consumer goods, art and design, and other specialized manufacturing markets. By combining software platforms with production capabilities, Materialise plays a role in enabling customized, data-driven manufacturing workflows and clinical applications within the broader digital manufacturing ecosystem.
$8.65
+$0.12 (+1.41%)
EOD Oct 23, 2026
Operating margin is thin at 4.12%. Limited cushion if revenue slows or costs rise.
Revenue declined 15.1% in the fiscal year ended Dec 2025.
At 32.66x earnings, the multiple leaves limited room for execution misses or growth deceleration.
32.66x earnings, 25.93x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€284M
▼ -15.1% YoY
Net Income (TTM)
€14M
▼ -51.3% YoY
Op. Margin
4.12%
▼ -0.2pp YoY
ROIC
2.70%
▼ -0.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€18M
▲ +51.0% YoY
Op. Cash Flow (TTM)
€31M
▼ -28.8% YoY
Net Debt
-€71M
Net Cash Position
Cash & Equiv.
€134M
3Y CAGR: +4.9%
Continue Research
Is Materialise NV ADR (MTLS) overvalued?
At a P/E of 32.7 and a price-to-free-cash-flow of 25.9, Materialise NV ADR (MTLS) trades above a two-stage DCF intrinsic value of about €7.18 per share, so at €8.65 the stock looks overvalued (17.0% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Materialise NV ADR scores 67/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
What is Materialise NV ADR's fair value?+
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €7.18 per share for MTLS, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €5.38. At today's €8.65, that puts the stock about 17.0% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Is Materialise NV ADR a high-quality business?+
Materialise NV ADR scores 67 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 4.1% operating margin and a 2.7% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Materialise NV ADR a good stock to buy right now?+
That depends on valuation and quality together, not either alone. MTLS currently trades above its estimated intrinsic value and scores 67/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Software - Application
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MTLS
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.